Cargando…

Decreased serum exosomal miR‐29a expression and its clinical significance in papillary thyroid carcinoma

BACKGROUND: Aberrant levels of circulating microRNAs (miRNAs) are potential biomarkers in papillary thyroid carcinoma (PTC) diagnosis and therapy. The aim of this study was to evaluate serum exosomal miR‐29a expression as a non‐invasive biomarker for PTC diagnosis and prognosis. METHODS: Quantitativ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wen, Qiuting, Wang, Yulou, Li, Xingjiang, Jin, Xiangguo, Wang, Guimei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843262/ https://www.ncbi.nlm.nih.gov/pubmed/33368640 http://dx.doi.org/10.1002/jcla.23560

Ejemplares similares

Serum miR-22 may be a biomarker for papillary thyroid cancer
por: Wang, Deping, et al.
Publicado: (2019)

miR-29a inhibits proliferation, invasion, and migration of papillary thyroid cancer by targeting DPP4
por: Wang, Yufei, et al.
Publicado: (2019)

BMSC-Derived Exosomal miR-29a Promotes Angiogenesis and Osteogenesis
por: Lu, Guo-dong, et al.
Publicado: (2020)

miR-146a and miR-146b in the diagnosis and prognosis of papillary thyroid carcinoma
por: Qiu, Zhenwei, et al.
Publicado: (2017)

Plasma exosomal miR-1290 and miR-29c-3p as diagnostic biomarkers for lung cancer
por: Zhang, Qian, et al.
Publicado: (2023)

Metformin decreases miR-122, miR-223 and miR-29a in women with polycystic ovary syndrome
por: Udesen, Pernille Bækgaard, et al.
Publicado: (2020)

Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma
por: Loosen, Sven H., et al.
Publicado: (2019)

Significance of serum miR‐29a in the occurrence and progression of diabetic nephropathy: A cross‐sectional study
por: Liu, Qian, et al.
Publicado: (2021)

Plasma Exosomal miR-146b-5p and miR-222-3p are Potential Biomarkers for Lymph Node Metastasis in Papillary Thyroid Carcinomas
por: Jiang, Ke, et al.
Publicado: (2020)

Predictive Significance of Serum MMP-9 in Papillary Thyroid Carcinoma
por: Xu, Dahai, et al.
Publicado: (2019)

Expression of miR-30c and miR-29b in prostate cancer and its diagnostic significance
por: Zhu, Chuanan, et al.
Publicado: (2018)

The Value of Serum Exosomal miR-184 in the Diagnosis of NSCLC
por: Li, Shujun, et al.
Publicado: (2022)

Elevated Circulating hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b in Type 2 Diabetes Mellitus with Diarrhea-Predominant Irritable Bowel Syndrome
por: Tao, Wenhua, et al.
Publicado: (2016)

Decreased expression of miR-29 family associated with autoimmune myasthenia gravis
por: Cron, Mélanie A., et al.
Publicado: (2020)

MiR-221, a potential prognostic biomarker for recurrence in papillary thyroid cancer
por: Dai, Lei, et al.
Publicado: (2017)

miR-126 inhibits papillary thyroid carcinoma growth by targeting LRP6
por: Wen, Qiang, et al.
Publicado: (2021)

TRIM29 inhibits miR-873-5P biogenesis via CYTOR to upregulate fibronectin 1 and promotes invasion of papillary thyroid cancer cells
por: Wu, Tong, et al.
Publicado: (2020)

MiR-29b-3p Inhibits Migration and Invasion of Papillary Thyroid Carcinoma by Downregulating COL1A1 and COL5A1
por: Wang, Congjun, et al.
Publicado: (2022)

Circulating miR-25-3p and miR-451a May Be Potential Biomarkers for the Diagnosis of Papillary Thyroid Carcinoma
por: Li, Min, et al.
Publicado: (2015)

Decreased serum exosomal miR-320a expression is an unfavorable prognostic factor in patients with hepatocellular carcinoma
por: Hao, Xinjie, et al.
Publicado: (2020)

Exosomal miRNA Expression Profiling and the Roles of Exosomal miR-4741, miR-32, miR-3149, and miR-6727 on Gastric Cancer Progression
por: Tang, Guojun, et al.
Publicado: (2022)

Pancreatic β cells control glucose homeostasis via the secretion of exosomal miR‐29 family
por: Li, Jing, et al.
Publicado: (2021)

Altered expression pattern of miR-29a, miR-29b and the target genes in myeloid leukemia
por: Xu, Ling, et al.
Publicado: (2014)

miR-21 facilitates the diagnostic value of miR-138 for papillary thyroid cancer in formalin-fixed paraffin-embedded tissues
por: Wang, Li, et al.
Publicado: (2019)

Exosome‐derived uterine miR‐218 isolated from cows with endometritis regulates the release of cytokines and chemokines
por: Wang, Xiangguo, et al.
Publicado: (2020)

The expression of miR-17 and miR-29a in placenta-derived exosomes in LPS-induced abortion mice model: An experimental study
por: Jalilvand, Tahereh, et al.
Publicado: (2021)

Correction: Circulating miR-25-3p and miR-451a May Be Potential Biomarkers for the Diagnosis of Papillary Thyroid Carcinoma
por: Li, Min, et al.
Publicado: (2015)

Loss of DNA methylation is related to increased expression of miR-21 and miR-146b in papillary thyroid carcinoma
por: Ortiz, Isabella Maria Dias Payão, et al.
Publicado: (2018)

Serum levels of miR-223 but not miR-21 are decreased in patients with neuroendocrine tumors
por: Hellberg, Teresa, et al.
Publicado: (2020)

miR-622 suppresses tumor formation by directly targeting VEGFA in papillary thyroid carcinoma
por: Wang, Renjie, et al.
Publicado: (2018)

Serum Exosomal miR-1290 is a Potential Biomarker for Lung Adenocarcinoma
por: Wu, Yining, et al.
Publicado: (2020)

Decreased Expression of miR-21, miR-26a, miR-29a, and miR-142-3p in CD4(+) T Cells and Peripheral Blood from Tuberculosis Patients
por: Kleinsteuber, Katja, et al.
Publicado: (2013)

Are pre-miR-146a and PTTG1 associated with papillary thyroid cancer?
por: Marino, Marco, et al.
Publicado: (2013)

miR-222 expression is correlated with the ATA risk stratifications in papillary thyroid carcinomas∗
por: Xiang, Dapeng, et al.
Publicado: (2019)

Diagnostic Significance of FNAB miRNA Expression in Papillary Thyroid Carcinoma
por: Laukienė, Romena, et al.
Publicado: (2022)

Retracted: The Value of Serum Exosomal miR-184 in the Diagnosis of NSCLC
por: Healthcare Engineering, Journal of
Publicado: (2023)

Exosomal miR-29b from cancer-associated fibroblasts inhibits the migration and invasion of hepatocellular carcinoma cells
por: Liu, Xingchao, et al.
Publicado: (2020)

A potential biomarker hsa-miR-200a-5p distinguishing between benign thyroid tumors with papillary hyperplasia and papillary thyroid carcinoma
por: Wang, Xian, et al.
Publicado: (2018)

MiR-221 Exacerbate Cell Proliferation and Invasion by Targeting TIMP3 in Papillary Thyroid Carcinoma
por: Diao, Yingbin, et al.
Publicado: (2017)

miR-182, of the miR-183 cluster family, is packaged in exosomes and is detected in human exosomes from serum, breast cells and prostate cells
por: Mihelich, Brittany L., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dqr7m7f1554o1t8a1ddtug6p27